Abstract Library

#2997 Benefits of 177Lu-DOTATATE in Patients with Advanced Neuroendocrine Tumours: Case Reports from Two Patients with High Disease Burden

Introduction: In the NETTER-1 study, peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE increased progression-free survival (PFS) and time to deterioration in quality of life (QoL) in patients with advanced midgut neuroendocrine tumours (NETs), compared with octreotide.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Wadsley J, Shah T,

Keywords: 177Lu-DOTATATE, metastases, quality of life,

#2223 Diagnostic Dilemma in a Patient with Recurrent Hypoglycaemia: An Unusual Case

Introduction: Recurrent hypoglycemia is a part of Whipple’s triad and usually points towards insulinoma as a cause. Presence of metastasis is uncommon in Insulinoma, and other causes should be ruled out.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Desai G

Authors: Desai G, Pande P, Shah R, Palepu J,

Keywords: proinsulinoma, hypoglycaemia, 213-bismuth prrt,

#2003 Comparison of Glucagon-Like-Peptide-1 (GLP-1) Receptor PET/CT, SPECT/CT and 3T MRI for the Localisation of Insulinomas: Evaluation of Accuracy in a Prospective Crossover Imaging Study

Introduction: Benign insulinomas are the most prevalent cause of endogenous hyperinsulinaemic hypoglycaemia (EHH) in adults and due to their small size difficult to localise.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Antwi A, Heye T, Fani M, Nicolas G, Merkle E,

Keywords: Insulinoma, neuroendocrine tumor, GLP-1R imaging,

#1101 Malignant Insulinoma in a Patient with Diabetes: Response to Treatment and a Return to Insulin Injections

Introduction: A 64 year old male with a fourteen year history of diabetes had been treated with insulin for eight years. Over a four week period he noticed that his insulin requirements were reducing and he experienced episodes of symptomatic hypoglycaemia and upper abdominal pain. Following referral a CT scan was performed which revealed numerous liver metastases and a 8.4 by 5.2 cm mass replacing the pancreas. Liver biopsy diagnosed a neuroendocrine tumour with a MIB-1 index of up to 18%. The tumour was somatostatin receptor positive as evidenced by an octreotide scan.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Sherriff D

Authors: Sherriff D, Drake B,

Keywords: insulinoma, diabetes, prrt,

#1063 Hypoglycaemia in a Patient with Glucagonoma-Coincidence of a Glucagonoma and Insulinoma in a Patient with Multiple Endocrine Neoplasia Type I

Introduction: We report the case of a 54 year old female with a known MEN1 syndrome with primary Hyperparathyroidism, a Prolactinoma and a pancreatic tumor. The patient complains about episodes of fatigue and sweating, both symptoms improve immediately after a meal.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Ploner F, Plank J, Humer-Fuchs U, Lax S, Noggler P,

Keywords: MEN1, Glucagonoma,